ctrl K

Watchlist Price Alert

Kindred Biosciences Inc. (KIN)

NASDAQ: KIN · Real-Time Price · USD

9.25

0.01 (0.11%)

At close: Apr 24, 2025, 3:47 PM

Kindred Biosciences Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	42.16M	4.26M	1.97M	n/a	n/a
Cost of Revenue	4.63M	587K	324K	n/a	n/a
Gross Profit	37.54M	3.67M	1.64M	n/a	n/a
Operating Income	-19.97M	-61.39M	-49.69M	-30.88M	-22.5M
Interest Income	n/a	n/a	n/a	n/a	n/a
Pretax Income	-21.8M	-61.39M	-49.69M	-30.88M	-22.5M
Net Income	-23.62M	-61.39M	-49.69M	-30.88M	-22.5M
Selling & General & Admin	21.98M	37.93M	26.5M	13.99M	8.31M
Research & Development	31.28M	28.31M	26.4M	17.66M	13.86M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	53.26M	66.24M	52.9M	31.65M	22.17M
Interest Expense	1.83M	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	4.42M	2.08M	1.47M
Cost & Expenses	57.89M	66.82M	53.22M	31.65M	22.17M
Income Tax Expense	1.83M	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	39.29M	38.66M	31M	25.08M	19.87M
Shares Outstanding (Diluted)	39.29M	38.66M	31M	25.08M	19.87M
EPS (Basic)	-0.6	-1.59	-1.6	-1.23	-1.13
EPS (Diluted)	-0.6	-1.59	-1.6	-1.23	-1.13
EBITDA	-15.29M	-58.85M	-48.88M	-30.4M	-22.34M
EBIT	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	4.68M	2.54M	805K	475K	155K